Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
Journal Information
Full Title: Emerg Infect Dis
Abbreviation: Emerg Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Communicable Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"additional information about public health impact of paxlovid as treatment for covid-19 united states the computer code referenced in this study is available from github ( https://github com/zhanweidu/pax )."
"Financial support was provided by the AIR@InnoHK Programme from Innovation and Technology Commission of the Government of the Hong Kong Special Administrative Region, the US National Institutes of Health (grant no. R01 AI151176), the Centers for Disease Control and Prevention COVID Supplement (grant no. U01IP001136), Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. 21200632) and National Natural Science Foundation of China (grant no. 82304204). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. B.J.C. consults for AstraZeneca, GSK, Moderna, Roche, Sanofi Pasteur, and Pfizer. "
"Financial support was provided by the AIR@InnoHK Programme from Innovation and Technology Commission of the Government of the Hong Kong Special Administrative Region, the US National Institutes of Health (grant no. R01 AI151176), the Centers for Disease Control and Prevention COVID Supplement (grant no. U01IP001136), Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. 21200632) and National Natural Science Foundation of China (grant no. 82304204). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025